Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : STEM -- StemCells, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (216)	2/25/1999 3:55:00 PM
From: Mike McFarland	Read Replies (2) \| Respond to of 805

Well I guess I will subscribe to Nature Biotechnology...either that or make frequent runs to the science stacks at Suzzallo. It just occurred to me to stop doing searches for "neural stem" etc and plug in Cytotherapeutics on the NB website. Here are the results of that query. Human ES cells: Can you build a business around them? Vicki Brower Nature Biotechnology February 1999 Volume 17 Number 2 pp 139- 142 Cell surface expression of a human IgC Fc chimera activates macrophages through Fc receptors Paul F. Stabila, Shou C. Wong, Faith A. Kaplan & Weng Tao Nature Biotechnology December 1998 Volume 16 Number 13 pp 1357- 1360 Xenotransplantation Aris Persidis Nature Biotechnology February 1999 Volume 17 Number 2 pp 205 - 206 I suppose it is typical to start digging in as you watch the price of your stock slip, heheh. By the time I'm down 20% and am thinking about getting stopped out, I usually have a nice thick folder of articles, quarterly reports, PR, and notes taken from the threads.